Introduction
A number of different techniques have been used to deliver genes to vascular cells. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] To date, viral systems have been more efficient than nonviral vehicles in vascular gene transfer. 10, 12, 13 However, the use of viral vectors in gene therapy has raised questions concerning their immunogenicity, oncogenic properties and unknown long-term effects.
14 Such safety concerns have not been linked to nonviral delivery of plasmid DNA. Furthermore, plasmids are easier to prepare and purify in large quantities than viral vectors. Efficient arterial gene transfer would be a beneficial tool for the treatment of vascular diseases, such as postangioplasty restenosis, postbypass atherosclerosis, peripheral atherosclerotic disease, stenosis of vascular prosthesis anastomoses and thrombus formation. 8, 13 Thus, there is a clear need to develop efficient nonviral gene transfer techniques for cardiovascular applications in vivo. In most conditions only a temporary expression of the transfected gene will be required to achieve a beneficial biological effect. 1, 7, 8 Cationic polymers have been widely used in gene transfer experiments in vitro and in vivo. [15] [16] [17] [18] [19] [20] [21] The purpose of the present study was to investigate the gene transfer efficiency of different liposomes and cationic polymers in vitro to smooth muscle cells (SMC) and endothelial cells (ECV 304) and to evaluate the most promising vehicles for in vivo gene delivery to rabbit carotid artery. Based on in vitro studies, fractured polyamidoamine dendrimers (generation 6) and PEI of 25 kDa and 800 kDa were chosen for in vivo study. Since behavior of cationic polymer-DNA complexes in vitro is dependent on the charge ratio, 18 different ± charge ratios were tested in an in vivo model. To date, very little is known about the optimal charge ratios for various cationic polymer-plasmid DNA complexes for arterial gene transfer.
Our results show that both fractured dendrimers and PEI-25 mediate efficient arterial transfer of ␤-galactosidase plasmid at ± charge ratios of 3 and 4, respectively. Whereas PEI-25 showed toxic effects with high ± charge ratios in vitro and possibly also in vivo, the fractured dendrimers did not show any signs of toxicity at ± charge ratio of 3.
Results
In vitro transfection efficiency Gene transfer efficiencies of different lipid formulations and cationic polymers in vitro are summarized in Table 1 . Fractured dendrimers had the highest transfection efficiency of 9.1% and 3.6% in SMC and ECV 304 cells, respectively. Transfection was most efficient with the highest ± charge ratio 6. PEI-25 was also found to be effective in both cells types. The most effective lipid was DOGS which transfected 3.5% (± charge ratio 4) and 2.7% (± charge ratio 8) of SMC and 0.3% of ECV 304 cells (± charge ratio 8).
In vitro toxicity
The survival of SMC varied from 64.0% to 96.9% (Table 1) . No obvious correlation was seen between lipid concentration and cell survival. Cells transfected with fractured dendrimer complexes had a high survival rate of 95.5% at ± charge ratio 1.5 which decreased to 90.5% when ± charge ratio was raised to 6. The effect of charge ratio on toxicity was more evident with PEI-25 where the survival rate decreased from 85.1% (± charge ratio 4.5) to 69.6% (± charge ratio 9). PEI-800 also showed toxicity at ± charge ratio of 9 with a survival rate of 64%. ECV 304 cells tended to have a lower survival rate than SMC. ECV 304 cells transfected with lipid-plasmid complexes had typically a higher survival rate than cells transfected with cationic polymer-plasmid complexes (Table 1) .
In vivo transfection efficiency
Results of in vivo gene transfer to rabbit carotid arteries are shown in Figure 1 . The highest transfection efficiency as measured by ␤-galactosidase activity was achieved with fractured dendrimer at ± charge ratio of 3 where 4.4 ± 1.7% of the cells in the adventitia and media showed ␤-galactosidase activity. Higher or lower ± charge ratios did not improve the transfection efficiency ( Figure 1 ). PEI-25 had an optimal ± charge ratio of 4 with a transfection efficiency of 2.8 ± 1.8%. PEI-800 showed a constant 1-2% gene transfer efficiency with all charge ratios studied. Naked DNA was capable of transfecting 0.5 ± 0.3% of the cells in the arterial wall ( Figure 1 ). In addition, fractured dendrimers and PEI at ± charge ratio 1 and fractured dendrimers at ± charge ratio 0.5 were tested. Transfection efficiency with these complexes was at the same level as complexes with ± charge ratios 1.5-2 (data not shown).
Representative histology of the arteries after the gene transfer is shown in Figure 2 . After extravascular gene delivery most of the ␤-galactosidase activity was seen in the adventitial layer and in medial SMC. No signs of inflammation were seen in any of the study groups. Macrophage-specific immunostaining was similar in all study groups, with PEI-25 being the only exception at ± charge ratio 8, where the percentage of macrophages of all arterial cells exceeded 10% (Figure 1b) . The arterial structure and endothelium remained intact throughout the experiments in all study groups (Figure 2 ).
Discussion
We have previously shown that adventitial transfer of VEGF plasmid-liposome into rabbit carotid arteries reduces intimal thickening and that adventitial gene transfer can have effects on the endothelium. 13 Adventitial delivery of plasmids and oligonucleotides has also been reported in a number of other applications. 8, 10, 22 In human atherosclerotic arteries, 5% transfection efficiency via the intravascular route has been recently achieved with adenoviruses. 23 We show here that the transfection efficiency with fractured dendrimers and PEI is clearly higher than that achieved previously with DOTMA/ DOPE liposomes. 10 Thus, it is conceivable that gene transfer with cationic polymer-plasmid complexes will become competitive with adenoviruses for in vivo gene delivery applications. Relatively high gene transfer efficiency observed with naked DNA is likely due to the effective in vivo gene transfer method utilized in the present study where an arterial collar serves as a physical gene transfer reservoir for the gene delivery solution.
Both fractured dendrimers and PEI form small toroidal complexes with DNA and exhibit considerable buffer and swelling capacity at low endosomal pH. 16, 18, 20 These factors have been suggested as crucial for the high in vitro transfection efficiency of fractured dendrimers and PEI as compared to polylysines.
16, 18 We found that in vitro cell culture experiments can be used to identify efficient in vivo gene transfer vehicles (fractured dendrimer and PEI-25), but the transfection efficiencies in vitro and in vivo at different ± charge ratios did not correlate with each other. Thus, charge ratios for each complex must be optimized in vivo. The size of the complexes varies with ± charge ratio 18 which may affect the interaction of the cationic polymer-plasmid complexes with anionic matrix compounds in the arterial wall. Intact dendrimers have also been used for cardiac gene transfer. 24 In vivo toxicity and immunogenicity of intact dendrimers are likely to be minimal. 25 In our experiments fractured dendrimers did not show any signs of inflammation or toxicity (Figure 2) . Systemic administration of plasmid carriers leads to interactions with plasma proteins and accumulation of genes into undesired locations, mostly in the lung and liver. 8, 26, 27 This leads to poor delivery to the desired target tissues. Local gene transfer with a small amount of plasmid DNA should reduce systemic spread of plasmids.
Intravascular gene delivery through atherosclerotic lesions and lipid-rich atheroma may also be low. 6, 8, 23 Furthermore, human lesions are frequently rich in connective tissue and contain only a limited number of transfectable cells in the intimal part of the lesion. To circumvent these problems adventitial gene delivery can be performed with a silastic or biodegradable collar, 13 biodegradable gel, 5 or direct injection into adventitia. 22 It is concluded that local gene transfer with cationic polymer-plasmid complexes provides an efficient way for the treatment of arterial diseases during vascular surgery, such as prosthesis and anastomosis operations and by-pass surgery. In vitro transfection efficiency assay Rabbit aortic RAASMC and human ECV 304 cells were plated at a density of 50 000 and 100 000 cells per plate (6 cm, Sarstedt, Leicester, USA), respectively. Cells were incubated for 24 h before transfection. ␤-Galactosidase (lacZ) expression plasmid 10 (2 g per plate) was complexed with lipids or cationic polymers to give ± charge ratios of 1-9 (see below). The complexes (total volume 170 l, 50 mm MES, 50 nm Hepes, 75 mm NaCl, pH 7.2) were allowed to stand at room temperature for 20 min, and added dropwise on to the cells. The cells were incubated for 5 h in serum-free medium (DME-H21) and washed twice with PBS before addition of the growth medium consisting of DME-H21 with 10% fetal calf serum and antibiotics (100 units/ml of penicillin and 100 g/ml of streptomycin). After 2 days cells were fixed with 3.7% formaldehyde for 15 min and washed twice with PBS. X-gal staining solution (1 mg/ml, 2 mm MgCl 2 , 5 mm K 3 Fe(CN) 6 , 5 mm K 4 Fe(CN) 6 , 1 × PBS)) was added on to the cells and incubated for 1 h. Blue X-gal-positive cells were counted and the transfection efficiency was expressed as the percentage of positive cells of the total number of cells. In vitro toxicity assay SMC or ECV 304 cells were plated in 96-well plates at density of 20 000 cells per well in 100 l of growth medium consisting of DME-H21 with 10% fetal calf serum and antibiotics (100 units/ml of penicillin and 100 g/ml of streptomycin). Cells were incubated for 24 h at 37°C. Growth medium was aspirated and 150 l serum-free medium added. DNA-carrier complexes were prepared by adding a solution of DNA in MES-Hepes to an equal volume of carrier in water in 96-well trays. Com-plex (50 l) containing 0.6 g of DNA and varying proportions of carrier were added to the serum-free medium. Cells were incubated at 37°C for 5 h before the complex and serum-free media were aspirated and 150 l of growth medium was added. Cells were incubated for 2 days after which the growth medium was replaced with serum-free medium (150 l). MTT-solution (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide, 10 l, 5 mg/ml) was then added and cells were incubated for 2 h. SDS/DMF buffer (200 g/ml SDS, 50% DMF, pH 4.7) was added and incubated for 19 h. Absorbance was measured at 570 nm. 16 Survival percentage was calculated as compared to mock-treated cells (100% survival).
Materials and methods

Preparation of plasmid-carrier complexes for in vivo transfection
For in vivo studies pSV-␤-galactosidase expression plasmid 10 was produced using Qiagen Giga kit (Qiagen, Hilden, Germany). Purified plasmid was analyzed for the absence of microbial contaminants and lipopolysaccharide (Limulus assay; Sigma). In each transfection 25 g of plasmid DNA was used. Sixth generation fractured PAMAM dendrimers 16 and PEI of molecular weights 25 kDa and 800 kDa 20 were used. Apparent ± charge ratio of the cationic polymer to plasmid was calculated on the following basis: 1 g of DNA contains 3.1 nmol phosphate anionic charges (assuming a mean molecular weight of 325 for a nucleotide sodium salt); 1 l of PEI (0.45 g/l) contains 10 nmol of amine cationic charges; sixth generation fractured dendrimer has 3.4 mol primary amines/mg. Cationic polymer was added to Ringer solution (volume 515-560 l, depending on the ± charge ratio) and 25 g (1 g/l) DNA was slowly added (total volume of solution 600 l). The solution was allowed to stand at room temperature for 30 min and was used for gene transfer within 2 h.
Experimental animals
Thirty-four New Zealand White male rabbits of 2.1-3.5 kg were used. Fentanyl-fluanisone (0.3 ml/kg, s.c.; Janssen Pharmaceutica, Beerse, Belgium) and midazolam (1.5 mg/kg, i.m.; Roche, Basel, Switzerland) were used for anesthesia. The left carotid artery was exposed using midline neck incision. The artery was carefully separated from the surrounding tissue and a 3 cm silastic collar (MediGene Oy, Kuopio, Finland) was positioned around the artery. 10 Rabbits were re-anesthetized for gene transfer, which was performed 5 days after the installation of the collar. 10 The collar was opened and filled with 600 l of the gene transfer solution. Rabbits were killed 3 days after the gene transfer and arteries were removed for histological analyses. All animal procedures were approved by the Animal Care and Use Committee, University of Kuopio, Finland.
Histological analysis
Collared arteries were divided into three equal parts: the proximal third was immersion-fixed in 4% paraformaldehyde/15% sucrose (pH 7.4) for 4 h, rinsed in 15% sucrose (pH 7.4) overnight and embedded in paraffin. The medial third was directly embedded in OCT compound and processed for frozen sections. In some rabbits part of the medial third was stored at −70°C for later analyses. The distal third was immersion-fixed in 4% paraformaldehyde/phosphate-buffered saline (pH 7.4) for 30 min, rinsed 24 h in phosphate buffer (pH 7.2) and embedded in OCT compound. 28 Ten randomly selected frozen sections (10 m) from each rabbit were stained with X-gal for 18 h to identify ␤-galactosidase-positive cells. Gene transfer efficiency was calculated independently by two observers (MPT and MOH) as a percentage of X-gal-positive cells of all arterial cells. 10 Mean values of the results are reported. Smooth muscle cells were identified using HHF-35 immunostaining (1:500 dilution, Enzo Diagnostics, Farmingdale, USA). Macrophages and endothelium were identified using RAM-11 (1:50 dilution; Dako, Hamburg, Germany) and CD-31 (1:50 dilution; Dako), respectively. 10 Hematoxylin was used as a nuclear stain. Paraffin sections were used for immunostainings and nuclear stainings.
